FDA Approved: AKYNZEO — Original Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approved AKYNZEO (netupitant and palonosetron) through an original application (NDA205718) for the prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

ORIG AP for AKYNZEO (NETUPITANT AND PALONOSETRON)